Hearing is central to early communication, social connection and learning, yet congenital or early-onset hearing loss can be difficult to recognise through routine observation alone. A baby may startle to loud sounds and still have a clinically important hearing impairment, which is why objective newborn hearing tests are valuable before discharge or during the first weeks of life.
Across Asia, screening systems vary widely according to birth rates, geography, public funding, workforce capacity and access to paediatric audiology. The FAOPS 2020 congress, planned in conjunction with PREBIC AA 2020 in Tokyo before its cancellation during the COVID-19 pandemic, reflected the region’s interest in perinatal medicine, neonatal care and research. Its official congress website remains a useful reminder of the collaborative foundations behind this field.
The principal aim of a neonatal hearing programme is to identify permanent childhood hearing loss early enough for families and clinicians to arrange diagnostic assessment, communication support and intervention. Screening does not provide a complete diagnosis. It separates babies who need further testing from those who are unlikely to have significant hearing loss at that point in time.
Most programmes use automated auditory brainstem response testing or otoacoustic emissions. These technologies are painless, quick and suitable for sleeping newborns. Automated auditory brainstem response is particularly useful for babies who spent time in intensive care because it can detect auditory nerve pathway problems that otoacoustic emissions may miss. Local protocols often combine the methods according to available equipment and risk factors.
Timing matters. A commonly used international benchmark is screening by one month, confirmation of hearing loss by three months and access to early intervention by six months. These targets are often called the “1-3-6” framework, although health systems may adapt them to local circumstances. Delays can occur when a baby moves between hospitals, a family changes address, contact details are incomplete or follow-up appointments are difficult to reach.
Universal newborn hearing screening is the preferred model where resources allow it because relying only on risk indicators misses many babies with hearing loss. Targeted programmes can be a practical first step in lower-resource settings, particularly when they focus on neonatal intensive care patients, a family history of childhood hearing loss, congenital infections, craniofacial differences, meningitis or exposure to medicines that may affect hearing.
A successful programme needs more than screening machines. Staff require training in test preparation, infection control, parent communication and accurate data entry. Hospitals also need a referral pathway to audiologists, ear, nose and throat specialists, paediatricians, genetic services and early-intervention providers. In countries with many languages, written information and consent conversations should be adapted for families who do not speak the dominant language.
Neonatal care should be approached as a connected pathway. Nutrition, infection prevention, respiratory care and developmental monitoring all influence the experience of families with premature or medically fragile babies. Research on probiotics and NEC illustrates how neonatal teams consider several linked outcomes at once; hearing screening should sit within that same coordinated model rather than operate as an isolated test.
A “refer” or “did not pass” result is not the same as confirmed hearing loss. Fluid in the middle ear, vernix in the ear canal, movement, background noise or an unsettled baby can affect the first screen. Families should receive clear information before leaving hospital, including the next appointment, the reason for it and a direct contact number if they need to reschedule.
The follow-up pathway usually includes a repeat screen and, when necessary, diagnostic audiology. Diagnostic testing may involve a detailed auditory brainstem response under natural sleep or sedation, tympanometry, behavioural assessment as the child develops and medical examination. The process should be tracked through a central register or reliable local system so that a missed appointment generates active outreach rather than silent discharge from care.
Australia offers useful examples of both opportunity and complexity. Large maternity centres in Sydney, Melbourne, Brisbane and Perth can often provide screening before discharge, while families in regional Queensland, Western Australia, the Northern Territory or remote South Australia may travel long distances for diagnostic services. Some babies leave hospital quickly after birth, and families may then rely on a general practitioner, maternal and child health nurse or community clinic to complete the pathway. Telehealth can support counselling and review, but it cannot replace every component of a hands-on audiology assessment.
Programme performance should be measured by more than the number of babies screened. Important indicators include coverage, the percentage receiving a result before discharge, referral rates, diagnostic completion, age at confirmation and age at commencement of intervention. Disaggregating results by region, language, socioeconomic status, Indigenous status and medical risk can reveal gaps hidden by national averages.
In Australia, services must consider the Disability Discrimination Act 1992 and the Australian Privacy Principles under the Privacy Act 1988 when communicating with families and managing screening records. Consent processes should be understandable, culturally safe and proportionate to the test. Aboriginal and Torres Strait Islander families may benefit from local Aboriginal health workers, community-controlled services and flexible appointment arrangements developed with the community rather than imposed from outside.
Cost and access also shape real-world choices. Public hospitals generally provide newborn screening within established maternity services, while private hospitals, independent audiology clinics and equipment suppliers operate in a mixed healthcare market. Medicare may cover some related medical consultations, but families can still face travel, parking, time-off-work and diagnostic costs. Clear referral information is especially important for families in Adelaide, Canberra or Hobart who may need to coordinate public and private services.
Hearing support should also be connected with broader child and family health. For example, discussions about feeding, oral development and preventive care can point families towards wider health resources, including work on oral health integration. This integrated approach helps parents understand that early development is monitored through several complementary services, not through one appointment alone.
Asian countries can strengthen neonatal hearing services by setting realistic stages of development. A hospital may begin with screening for babies in intensive care, establish a referral register and train staff before expanding to universal coverage. National standards can then define acceptable equipment, staff competency, data reporting and maximum waiting times. Regional cooperation is valuable because neighbouring countries often face similar shortages of audiologists, biomedical engineers and paediatric ENT specialists.
Prevention and perinatal health also influence the demand for follow-up. Antenatal care, immunisation, infection prevention and safe neonatal practice can reduce some risks associated with developmental disability, while maternal health education supports informed conversations before birth. Resources discussing maternal exercise benefits show how perinatal education can address health behaviours well before a newborn enters a screening pathway.
For Australian services, reliability depends on closing the loop between the birth hospital, primary care, audiology and early intervention. A baby who screens positive in Melbourne should not be lost when the family moves to regional Victoria; a newborn transferred from Darwin to Adelaide needs records that travel with the clinical team; and families who miss an appointment should receive respectful, practical contact rather than blame. Interpreters, SMS reminders, transport assistance and flexible clinic hours can make a measurable difference.
| Programme feature | Universal hospital-based model | Targeted or phased model |
|---|---|---|
| Population covered | All newborns, regardless of risk | Babies with medical or family risk factors first |
| Main strength | Detects cases without obvious risk indicators | More affordable where equipment and staff are limited |
| Main limitation | Requires substantial workforce, data systems and follow-up | Can miss babies with no recognised risk factor |
| Typical technologies | Otoacoustic emissions and/or automated auditory brainstem response | Often automated auditory brainstem response for high-risk infants |
| Follow-up need | Central tracking and diagnostic audiology for every refer result | Strong referral protocols for participating hospitals |
| Australian application | Suitable for large maternity networks with regional links | Useful as an interim approach in remote or under-resourced settings |
Clinicians, programme managers and policymakers can use these principles to review their own pathway: test every eligible newborn where possible, explain results plainly, track every referral and design services around the geography and culture of the families they serve. Strong neonatal hearing screening is ultimately measured by children reaching timely diagnostic and developmental support, not by equipment installed or tests recorded.